A Double-blind, Parallel-group Phase III Study of TK-041 in Patients with Chronic Urticaria
Phase 3
- Conditions
- Chronic urticaria
- Registration Number
- JPRN-jRCT2080222734
- Lead Sponsor
- TEIKOKU SEIYAKU CO., LTD.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 270
Inclusion Criteria
Chronic urticaria for over a month
Exclusion Criteria
Other skin diseases which interfere with the evaluation
Hypersensitivity to antihistamine drugs or study drug
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method